Target intelligence / Profile preview

Ubiquitin specific peptidase 17 like family member 29 (USP17L29)

Target
USP17L29
Molecular classification
Enzyme, Deubiquitinating enzyme (DUB), Cysteine-type peptidase
01

Overview

Ubiquitin specific peptidase 17 like family member 29 (USP17L29) is a member of the deubiquitinating enzyme family, functioning as a cysteine-type peptidase that removes ubiquitin moieties from specific proteins, thereby regulating multiple cellular processes such as cell proliferation, cell cycle progression, apoptosis, and cell migration. USP17L29 is rapidly induced in response to cytokine and chemokine stimulation and is necessary for both directional and random cell motility, acting downstream of chemokine receptors to facilitate cytoskeletal rearrangement via small GTPases. Its role in cell migration, proliferation, and survival implicates USP17L29 as a potential therapeutic target in inflammation, immune regulation, and cancer, particularly in processes related to metastasis and tissue invasion. No clinically approved drugs specifically target USP17L29, and inhibition may disrupt essential biological functions in both normal and malignant cells.

Other names
Ubiquitin carboxyl-terminal hydrolase 17-like protein 24USP17L24USP17USP17HUSP17IUSP17JUSP17KUSP17LUSP17MDeubiquitinating enzyme 17Ubiquitin thioesterase 17Ubiquitin-specific-processing protease 17
02

Mechanism of action

Inhibition of protein deubiquitination (hypothetical for investigational agents targeting DUB activity); Suppression of cell migration and proliferation if deubiquitinase activity is blocked

03

Biological functions

Protein deubiquitinationCell proliferationRegulation of cell cycle progressionApoptosisRegulation of cell migration and chemotaxisCytoskeletal rearrangement
04

Disease associations

CancerInflammationMetastatic disease
05

Safety considerations

Potential for affecting normal cell cycle, apoptosis, and immune cell chemotaxis due to essential cellular functions

Beyond the preview

Go deeper on Ubiquitin specific peptidase 17 like family member 29 (USP17L29).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin specific peptidase 17 like family member 29 (USP17L29).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call